Cancer stem cells, epithelial-mesenchymal transition, and drug resistance in high-grade ovarian serous carcinoma

Human Pathology

Volumn 44, Issue 11, 2013, Pages 2373-2384

  Chen, Xiaoxiang ^a,b,c   Zhang, Jing ^d   Zhang, Zhihong ^e   Li, Hongxia ^e   Cheng, Wenjun ^e   Liu, Jinsong ^c,e  

^a JIANGSU CANCER HOSPITAL   (China)

^b SOUTHEAST UNIVERSITY   (China)

^c UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

^d FOURTH MILITARY MEDICAL UNIVERSITY   (China)

^e THE FIRST AFFILIATED HOSPITAL OF NANJING MEDICAL UNIVERSITY   (China)

Author keywords

Cancer stem cell; Epithelial mesenchymal transition; High grade ovarian serous cancer

Indexed keywords

ALDEHYDE DEHYDROGENASE; BRCA1 PROTEIN; BRCA2 PROTEIN; BREAST CANCER RESISTANCE PROTEIN; CD133 ANTIGEN; CD24 ANTIGEN; CISPLATIN; DOXORUBICIN; EPITHELIAL CELL ADHESION MOLECULE; HERMES ANTIGEN; METHOTREXATE; MYELOID DIFFERENTIATION FACTOR 88; NESTIN; OCTAMER TRANSCRIPTION FACTOR 4; PACLITAXEL; PROTEIN P53; STEM CELL FACTOR RECEPTOR; TRANSCRIPTION FACTOR NANOG; TRANSCRIPTION FACTOR SOX2; TUMOR MARKER;

ARTICLE; CANCER GRADING; CANCER RESISTANCE; CANCER STEM CELL; CARCINOGENESIS; CELL DIFFERENTIATION; CELL RENEWAL; DRUG MECHANISM; DRUG PENETRATION; DRUG RESPONSE; EPITHELIAL MESENCHYMAL TRANSITION; HUMAN; MALIGNANT TRANSFORMATION; NONHUMAN; OVARY CARCINOMA;

EID: 84885612943     PISSN: 00468177     EISSN: 15328392     Source Type: Journal    
DOI: 10.1016/j.humpath.2013.05.001     Document Type: Review

References (134)

1. L. Dubeau The cell of origin of ovarian epithelial tumours Lancet Oncol 9 2008 1191 1197
2. S.A. Cannistra Cancer of the ovary N Engl J Med 351 2004 2519 2529
3. A. Jemal, E. Ward, Y. Hao, and M. Thun Trends in the leading causes of death in the United States, 1970-2002 JAMA 294 2005 1255 1259
4. R.F. Ozols Challenges for chemotherapy in ovarian cancer Ann Oncol 17 Suppl 5 2006 v181 v187
5. E. Bjorkholm, F. Pettersson, N. Einhorn, I. Krebs, B. Nilsson, and B. Tjernberg Long-term follow-up and prognostic factors in ovarian carcinoma. The radiumhemmet series 1958 to 1973 Acta Radiol Oncol 21 1982 413 419
6. T. Hogberg, J. Carstensen, and E. Simonsen Treatment results and prognostic factors in a population-based study of epithelial ovarian cancer Gynecol Oncol 48 1993 38 49
7. B. Sorbe, B. Frankendal, and B. Veress Importance of histologic grading in the prognosis of epithelial ovarian carcinoma Obstet Gynecol 59 1982 576 582
8. J.S. Fleming, C.R. Beaugie, I. Haviv, G. Chenevix-Trench, and O.L. Tan Incessant ovulation, inflammation and epithelial ovarian carcinogenesis: revisiting old hypotheses Mol Cell Endocrinol 247 2006 4 21
9. K. Levanon, C. Crum, and R. Drapkin New insights into the pathogenesis of serous ovarian cancer and its clinical impact J Clin Oncol 26 2008 5284 5293
10. D.W. Kindelberger, Y. Lee, and A. Miron Intraepithelial carcinoma of the fimbria and pelvic serous carcinoma: evidence for a causal relationship Am J Surg Pathol 31 2007 161 169
11. D.A. Bell, T.A. Longacre, and J. Prat Serous borderline (low malignant potential, atypical proliferative) ovarian tumors: workshop perspectives Hum Pathol 35 2004 934 948
12. C.G. Przybycin, R.J. Kurman, B.M. Ronnett, M. Shih Ie, and R. Vang Are all pelvic (nonuterine) serous carcinomas of tubal origin? Am J Surg Pathol 34 2010 1407 1416
13. Y. Lee, A. Miron, and R. Drapkin A candidate precursor to serous carcinoma that originates in the distal fallopian tube J Pathol 211 2007 26 35
14. M. Mehrad, G. Ning, E.Y. Chen, K.K. Mehra, and C.P. Crum A pathologist's road map to benign, precancerous, and malignant intraepithelial proliferations in the fallopian tube Adv Anat Pathol 17 2010 293 302
15. R.J. Kurman, and Ie M. Shih Molecular pathogenesis and extraovarian origin of epithelial ovarian cancer - shifting the paradigm Hum Pathol 42 2011 918 931
16. C.P. Crum, F.D. McKeon, and W. Xian The oviduct and ovarian cancer: causality, clinical implications, and «targeted prevention» Clin Obstet Gynecol 55 2012 24 35
17. M.S. Wicha, S. Liu, and G. Dontu Cancer stem cells: an old idea - a paradigm shift Cancer Res 66 2006 1883 1890 [discussion 1895-6]
18. G.J. Spangrude, S. Heimfeld, and I.L. Weissman Purification and characterization of mouse hematopoietic stem cells Science 241 1988 58 62
19. M.F. Clarke, J.E. Dick, and P.B. Dirks Cancer stem cells - perspectives on current status and future directions: AACR workshop on cancer stem cells Cancer Res 66 2006 9339 9344
20. A.V. Krivtsov, D. Twomey, and Z. Feng Transformation from committed progenitor to leukaemia stem cell initiated by MLL-AF9 Nature 442 2006 818 822
21. M. Dean Cancer stem cells: redefining the paradigm of cancer treatment strategies Mol Interv 6 2006 140 148
22. M.P. Ponnusamy, P. Seshacharyulu, A. Vaz, P. Dey, and S.K. Batra MUC4 stabilizes HER2 expression and maintains the cancer stem cell population in ovarian cancer cells J Ovarian Res 4 2011 7
23. M.D. Curley, V.A. Therrien, and C.L. Cummings CD133 expression defines a tumor initiating cell population in primary human ovarian cancer Stem Cells 27 2009 2875 2883
24. M. Geens, H. Van de Velde, G. De Block, E. Goossens, A. Van Steirteghem, and H. Tournaye The efficiency of magnetic-activated cell sorting and fluorescence-activated cell sorting in the decontamination of testicular cell suspensions in cancer patients Hum Reprod 22 2007 733 742
25. J. Dou, C. Jiang, and J. Wang Using ABCG2-molecule-expressing side population cells to identify cancer stem-like cells in a human ovarian cell line Cell Biol Int 35 2011 227 234
26. S. Hosonuma, Y. Kobayashi, and S. Kojo Clinical significance of side population in ovarian cancer cells Hum Cell 24 2011 9 12
27. M.Y. Fong, and S.S. Kakar The role of cancer stem cells and the side population in epithelial ovarian cancer Histol Histopathol 25 2010 113 120
28. C. Hirschmann-Jax, A.E. Foster, and G.G. Wulf A distinct "side population" of cells with high drug efflux capacity in human tumor cells Proc Natl Acad Sci U S A 101 2004 14228 14233
29. M.M. Ho, A.V. Ng, S. Lam, and J.Y. Hung Side population in human lung cancer cell lines and tumors is enriched with stem-like cancer cells Cancer Res 67 2007 4827 4833
30. P. Zhang, Y. Zhang, L. Mao, Z. Zhang, and W. Chen Side population in oral squamous cell carcinoma possesses tumor stem cell phenotypes Cancer Lett 277 2009 227 234
31. A.H. Schinkel, and J.W. Jonker Mammalian drug efflux transporters of the ATP binding cassette (ABC) family: an overview Adv Drug Deliv Rev 55 2003 3 29
32. X.W. Ding, J.H. Wu, and C.P. Jiang ABCG2: a potential marker of stem cells and novel target in stem cell and cancer therapy Life Sci 86 2010 631 637
33. G. Dontu, W.M. Abdallah, and J.M. Foley In vitro propagation and transcriptional profiling of human mammary stem/progenitor cells Genes Dev 17 2003 1253 1270
34. N. Uchida, D.W. Buck, and D. He Direct isolation of human central nervous system stem cells Proc Natl Acad Sci U S A 97 2000 14720 14725
35. A.T. Collins, P.A. Berry, C. Hyde, M.J. Stower, and N.J. Maitland Prospective identification of tumorigenic prostate cancer stem cells Cancer Res 65 2005 10946 10951
36. C. Li, D.G. Heidt, and P. Dalerba Identification of pancreatic cancer stem cells Cancer Res 67 2007 1030 1037
37. P. Dalerba, S.J. Dylla, and I.K. Park Phenotypic characterization of human colorectal cancer stem cells Proc Natl Acad Sci U S A 104 2007 10158 10163
38. C.F. Kim, E.L. Jackson, and A.E. Woolfenden Identification of bronchioalveolar stem cells in normal lung and lung cancer Cell 121 2005 823 835
39. R. Galli, E. Binda, and U. Orfanelli Isolation and characterization of tumorigenic, stem-like neural precursors from human glioblastoma Cancer Res 64 2004 7011 7021
40. J. Lee, S. Kotliarova, and Y. Kotliarov Tumor stem cells derived from glioblastomas cultured in bFGF and EGF more closely mirror the phenotype and genotype of primary tumors than do serum-cultured cell lines Cancer Cell 9 2006 391 403
41. T. Kondo, T. Setoguchi, and T. Taga Persistence of a small subpopulation of cancer stem-like cells in the C6 glioma cell line Proc Natl Acad Sci U S A 101 2004 781 786
42. B.A. Reynolds, and S. Weiss Clonal and population analyses demonstrate that an EGF-responsive mammalian embryonic CNS precursor is a stem cell Dev Biol 175 1996 1 13
43. S. Weiss, C. Dunne, and J. Hewson Multipotent CNS stem cells are present in the adult mammalian spinal cord and ventricular neuroaxis J Neurosci 16 1996 7599 7609
44. L. Wang, R. Mezencev, N.J. Bowen, L.V. Matyunina, and J.F. McDonald Isolation and characterization of stem-like cells from a human ovarian cancer cell line Mol Cell Biochem 363 2012 257 268
45. I. Kryczek, S. Liu, and M. Roh Expression of aldehyde dehydrogenase and CD133 defines ovarian cancer stem cells Int J Cancer 130 2012 29 39
46. O. Soritau, C.I. Tomuleasa, and E. Pall Enhanced chemoresistance and tumor sphere formation as a laboratory model for peritoneal micrometastasis in epithelial ovarian cancer Rom J Morphol Embryol 51 2010 259 264
47. T. Liu, W. Cheng, D. Lai, Y. Huang, and L. Guo Characterization of primary ovarian cancer cells in different culture systems Oncol Rep 23 2010 1277 1284
48. M. Al-Hajj, M.S. Wicha, A. Benito-Hernandez, S.J. Morrison, and M.F. Clarke Prospective identification of tumorigenic breast cancer cells Proc Natl Acad Sci U S A 100 2003 3983 3988
49. S.K. Singh, I.D. Clarke, and M. Terasaki Identification of a cancer stem cell in human brain tumors Cancer Res 63 2003 5821 5828
50. R. Gangemi, L. Paleari, and A.M. Orengo Cancer stem cells: a new paradigm for understanding tumor growth and progression and drug resistance Curr Med Chem 16 2009 1688 1703
51. C.A. O'Brien, A. Pollett, S. Gallinger, and J.E. Dick A human colon cancer cell capable of initiating tumour growth in immunodeficient mice Nature 445 2007 106 110
52. + hepatocellular carcinoma cells as cancer stem/progenitor cells Biochem Biophys Res Commun 351 2006 820 824
53. M.E. Prince, R. Sivanandan, and A. Kaczorowski Identification of a subpopulation of cells with cancer stem cell properties in head and neck squamous cell carcinoma Proc Natl Acad Sci U S A 104 2007 973 978
54. S.K. Singh, C. Hawkins, and I.D. Clarke Identification of human brain tumour initiating cells Nature 432 2004 396 401
55. - metastatic colon cancer cells initiate tumors J Clin Invest 118 2008 2111 2120
56. L. Ricci-Vitiani, D.G. Lombardi, and E. Pilozzi Identification and expansion of human colon-cancer-initiating cells Nature 445 2007 111 115
57. S. Bao, Q. Wu, and R.E. McLendon Glioma stem cells promote radioresistance by preferential activation of the DNA damage response Nature 444 2006 756 760
58. R. Chen, M.C. Nishimura, and S.M. Bumbaca A hierarchy of self-renewing tumor-initiating cell types in glioblastoma Cancer Cell 17 2010 362 375
59. J. Wang, P.O. Sakariassen, and O. Tsinkalovsky CD133 negative glioma cells form tumors in nude rats and give rise to CD133 positive cells Int J Cancer 122 2008 761 768
60. X.D. Zhou, X.Y. Wang, and F.J. Qu Detection of cancer stem cells from the C6 glioma cell line J Int Med Res 37 2009 503 510
61. X. Zheng, G. Shen, X. Yang, and W. Liu Most C6 cells are cancer stem cells: evidence from clonal and population analyses Cancer Res 67 2007 3691 3697
62. - subpopulations of A549 and H446 cells contain cancer-initiating cells Cancer Sci 100 2009 1040 1046
63. E. Quintana, M. Shackleton, M.S. Sabel, D.R. Fullen, T.M. Johnson, and S.J. Morrison Efficient tumour formation by single human melanoma cells Nature 456 2008 593 598
64. M. Shackleton, E. Quintana, E.R. Fearon, and S.J. Morrison Heterogeneity in cancer: cancer stem cells versus clonal evolution Cell 138 2009 822 829
65. E. Quintana, M. Shackleton, and H.R. Foster Phenotypic heterogeneity among tumorigenic melanoma cells from patients that is reversible and not hierarchically organized Cancer Cell 18 2010 510 523
66. S.A. Bapat, A.M. Mali, C.B. Koppikar, and N.K. Kurrey Stem and progenitor-like cells contribute to the aggressive behavior of human epithelial ovarian cancer Cancer Res 65 2005 3025 3029
67. + ovarian cancer cells Oncogene 28 2009 209 218
68. G. Ferrandina, G. Bonanno, and L. Pierelli Expression of CD133-1 and CD133-2 in ovarian cancer Int J Gynecol Cancer 18 2008 506 514
69. I.A. Silva, S. Bai, and K. McLean Aldehyde dehydrogenase in combination with CD133 defines angiogenic ovarian cancer stem cells that portend poor patient survival Cancer Res 71 2011 3991 4001
70. S. Zhang, C. Balch, and M.W. Chan Identification and characterization of ovarian cancer-initiating cells from primary human tumors Cancer Res 68 2008 4311 4320
71. L. Luo, J. Zeng, and B. Liang Ovarian cancer cells with the CD117 phenotype are highly tumorigenic and are related to chemotherapy outcome Exp Mol Pathol 91 2011 596 602
72. A.B. Alvero, R. Chen, and H.H. Fu Molecular phenotyping of human ovarian cancer stem cells unravels the mechanisms for repair and chemoresistance Cell Cycle 8 2009 158 166
73. - ovarian cancer cells demonstrate cancer stem cell properties and correlate to survival Clin Exp Metastasis 29 2012 939 948
74. J. Zhang, D.Y. Chang, I. Mercado-Uribe, and J. Liu Sex-determining region Y-box 2 expression predicts poor prognosis in human ovarian carcinoma Hum Pathol 43 2012 1405 1412
75. J. Zhang, X. Guo, D.Y. Chang, D.G. Rosen, I. Mercado-Uribe, and J. Liu CD133 expression associated with poor prognosis in ovarian cancer Mod Pathol 25 2012 456 464
76. Zhang J, Chang B, Liu J. CD44 standard form expression is correlated with high-grade and advanced stage ovarian carcinoma but not prognosis. Hum Pathol [Epub ahead of print].
77. B. Chang, G. Liu, and F. Xue ALDH1 expression correlates with favorable prognosis in ovarian cancers Mod Pathol 22 2009 817 823
78. L. Ma, D. Lai, T. Liu, W. Cheng, and L. Guo Cancer stem-like cells can be isolated with drug selection in human ovarian cancer cell line SKOV3 Acta Biochim Biophys Sin (Shanghai) 42 2010 593 602
79. S.A. Bapat Human ovarian cancer stem cells Reproduction 140 2010 33 41
80. Y. Kobayashi, K. Seino, and S. Hosonuma Side population is increased in paclitaxel-resistant ovarian cancer cell lines regardless of resistance to cisplatin Gynecol Oncol 121 2011 390 394
81. L. Hu, C. McArthur, and R.B. Jaffe Ovarian cancer stem-like side-population cells are tumourigenic and chemoresistant Br J Cancer 102 2010 1276 1283
82. Q.E. Wang, C. Han, K. Milum, and A.A. Wani Stem cell protein Piwil2 modulates chromatin modifications upon cisplatin treatment Mutat Res 708 2011 59 68
83. N.K. Kurrey, S.P. Jalgaonkar, and A.V. Joglekar Snail and slug mediate radioresistance and chemoresistance by antagonizing p53-mediated apoptosis and acquiring a stem-like phenotype in ovarian cancer cells Stem Cells 27 2009 2059 2068
84. C. Calabrese, H. Poppleton, and M. Kocak A perivascular niche for brain tumor stem cells Cancer Cell 11 2007 69 82
85. C.E. Eyler, and J.N. Rich Survival of the fittest: cancer stem cells in therapeutic resistance and angiogenesis J Clin Oncol 26 2008 2839 2845
86. R. Lis, C. Touboul, and P. Mirshahi Tumor associated mesenchymal stem cells protects ovarian cancer cells from hyperthermia through CXCL12 Int J Cancer 128 2011 715 725
87. J.A. Cho, H. Park, and E.H. Lim Exosomes from ovarian cancer cells induce adipose tissue-derived mesenchymal stem cells to acquire the physical and functional characteristics of tumor-supporting myofibroblasts Gynecol Oncol 123 2011 379 386
88. D. Kong, Y. Li, Z. Wang, and F.H. Sarkar Cancer stem cells and epithelial-to-mesenchymal transition (EMT)-phenotypic cells: are they cousins or twins? Cancers (Basel) 3 2011 716 729
89. E.D. Hay The mesenchymal cell, its role in the embryo, and the remarkable signaling mechanisms that create it Dev Dyn 233 2005 706 720
90. S.A. Mani, W. Guo, and M.J. Liao The epithelial-mesenchymal transition generates cells with properties of stem cells Cell 133 2008 704 715
91. J.P. Thiery, and J.P. Sleeman Complex networks orchestrate epithelial-mesenchymal transitions Nat Rev Mol Cell Biol 7 2006 131 142
92. J.P. Thiery Epithelial-mesenchymal transitions in tumour progression Nat Rev Cancer 2 2002 442 454
93. J.P. Thiery, H. Acloque, R.Y. Huang, and M.A. Nieto Epithelial- mesenchymal transitions in development and disease Cell 139 2009 871 890
94. E. Tomaskovic-Crook, E.W. Thompson, and J.P. Thiery Epithelial to mesenchymal transition and breast cancer Breast Cancer Res 11 2009 213
95. B.G. Hollier, K. Evans, and S.A. Mani The epithelial-to-mesenchymal transition and cancer stem cells: a coalition against cancer therapies J Mammary Gland Biol Neoplasia 14 2009 29 43
96. Z. Wang, Y. Li, and A. Ahmad Targeting miRNAs involved in cancer stem cell and EMT regulation: an emerging concept in overcoming drug resistance Drug Resist Updat 13 2010 109 118
97. A. Singh, and J. Settleman EMT, cancer stem cells and drug resistance: an emerging axis of evil in the war on cancer Oncogene 29 2010 4741 4751
98. T. Blick, H. Hugo, and E. Widodo Epithelial mesenchymal transition traits in human breast cancer cell lines parallel the CD44(hi/)CD24 (lo/-) stem cell phenotype in human breast cancer J Mammary Gland Biol Neoplasia 15 2010 235 252
99. L. Caja, E. Bertran, J. Campbell, N. Fausto, and I. Fabregat The transforming growth factor-beta (TGF-beta) mediates acquisition of a mesenchymal stem cell-like phenotype in human liver cells J Cell Physiol 226 2011 1214 1223
100. T. Vincent, E.P. Neve, and J.R. Johnson A SNAIL1-SMAD3/4 transcriptional repressor complex promotes TGF-beta mediated epithelial-mesenchymal transition Nat Cell Biol 11 2009 943 950
101. A. Martin, and A. Cano Tumorigenesis: Twist1 links EMT to self-renewal Nat Cell Biol 12 2010 924 925
102. D.G. Phinney Twist, epithelial-to-mesenchymal transition, and stem cells Stem Cells 29 2011 3 4
103. M.H. Yang, D.S. Hsu, and H.W. Wang Bmi1 is essential in Twist1-induced epithelial-mesenchymal transition Nat Cell Biol 12 2010 982 992
104. J. Zavadil A spotlight on regulatory networks connecting EMT and cancer stem cells Cell Cycle 9 2010 2927
105. P.B. Gupta, C.L. Chaffer, and R.A. Weinberg Cancer stem cells: mirage or reality? Nat Med 15 2009 1010 1012
106. C. Franci, M. Takkunen, and N. Dave Expression of Snail protein in tumor-stroma interface Oncogene 25 2006 5134 5144
107. J. Massague TGFbeta in cancer Cell 134 2008 215 230
108. J. Yang, and R.A. Weinberg Epithelial-mesenchymal transition: at the crossroads of development and tumor metastasis Dev Cell 14 2008 818 829
109. Y. Nisimoto, R. Tsubouchi, and B.A. Diebold Activation of NADPH oxidase 1 in tumour colon epithelial cells Biochem J 415 2008 57 65
110. A.E. Berezhnoi, A.A. Vainson, and N.N. Kasatkina High-dose gamma-irradiation enhance expression of transgene under control of immediate-early CMV promoter in stably transfected tumor cells] Mol Biol (Mosk) 42 2008 501 509
111. P.A. Gregory, A.G. Bert, and E.L. Paterson The miR-200 family and miR-205 regulate epithelial to mesenchymal transition by targeting ZEB1 and SIP1 Nat Cell Biol 10 2008 593 601
112. A.P. Morel, M. Lievre, C. Thomas, G. Hinkal, S. Ansieau, and A. Puisieux Generation of breast cancer stem cells through epithelial-mesenchymal transition PLoS One 3 2008 e2888
113. L. Cao, M. Shao, J. Schilder, T. Guise, K.S. Mohammad, and D. Matei Tissue transglutaminase links TGF-beta, epithelial to mesenchymal transition and a stem cell phenotype in ovarian cancer Oncogene 31 2012 2521 2534
114. P. Yue, X. Zhang, and D. Paladino Hyperactive EGF receptor, Jaks and Stat3 signaling promote enhanced colony-forming ability, motility and migration of cisplatin-resistant ovarian cancer cells Oncogene 31 2012 2309 2322
115. A. Latifi, K. Abubaker, and N. Castrechini Cisplatin treatment of primary and metastatic epithelial ovarian carcinomas generates residual cells with mesenchymal stem cell-like profile J Cell Biochem 112 2011 2850 2864
116. P.P. Shah, and S.S. Kakar Pituitary tumor transforming gene induces epithelial to mesenchymal transition by regulation of Twist, Snail, Slug, and E-cadherin Cancer Lett 311 2011 66 76
117. A. Chao, C.Y. Lin, and Y.S. Lee Regulation of ovarian cancer progression by microRNA-187 through targeting Disabled homolog-2 Oncogene 31 2012 764 775
118. C.H. Tseng, K.D. Murray, M.F. Jou, S.M. Hsu, H.J. Cheng, and P.H. Huang Sema3E/plexin-D1 mediated epithelial-to-mesenchymal transition in ovarian endometrioid cancer PLoS One 6 2011 e19396
119. J. Chen, L. Wang, L.V. Matyunina, C.G. Hill, and J.F. McDonald Overexpression of miR-429 induces mesenchymal-to-epithelial transition (MET) in metastatic ovarian cancer cells Gynecol Oncol 121 2011 200 205
120. J. Wu, Z. Liu, and C. Shao HMGA2 overexpression-induced ovarian surface epithelial transformation is mediated through regulation of EMT genes Cancer Res 71 2011 349 359
121. L. Rosano, R. Cianfrocca, and F. Spinella Acquisition of chemoresistance and EMT phenotype is linked with activation of the endothelin A receptor pathway in ovarian carcinoma cells Clin Cancer Res 17 2011 2350 2360
122. J.J. Wei, J. Wu, and C. Luan HMGA2: a potential biomarker complement to P53 for detection of early-stage high-grade papillary serous carcinoma in fallopian tubes Am J Surg Pathol 34 2010 18 26
123. L. Jia, S. Zhang, and Y. Ye Paclitaxel inhibits ovarian tumor growth by inducing epithelial cancer cells to benign fibroblast-like cells Cancer Lett 326 2012 176 182
124. S. Zhang, I. Mercado-Uribe, Z. Xing, B. Sun, and J. Kuang Generation of cancer stem-like cells through the formation of polyploid giant cancer cells 2013 10.1038/onc.2013.96
125. M.C. Lim, Y.J. Song, S.S. Seo, C.W. Yoo, S. Kang, and S.Y. Park Residual cancer stem cells after interval cytoreductive surgery following neoadjuvant chemotherapy could result in poor treatment outcomes for ovarian cancer Onkologie 33 2010 324 330
126. M.F. Shi, J. Jiao, and W.G. Lu Identification of cancer stem cell-like cells from human epithelial ovarian carcinoma cell line Cell Mol Life Sci 67 2010 3915 3925
127. P.P. Szotek, R. Pieretti-Vanmarcke, and P.T. Masiakos Ovarian cancer side population defines cells with stem cell-like characteristics and Mullerian Inhibiting Substance responsiveness Proc Natl Acad Sci U S A 103 2006 11154 11159
128. P. Gasparini, G. Bertoloni, and M. Binda Molecular cytogenic characterization of stem-like cancer cells isolated from established cell lines Cancer Lett 296 2010 206 215
129. L. Moserle, S. Indraccolo, and M. Ghisi The side population of ovarian cancer cells is a primary target of IFN-alpha antitumor effects Cancer Res 68 2008 5658 5669
130. S. Indraccolo, V. Tisato, and V. Tosello Inter-feron-alpha gene therapy by lentiviral vectors contrasts ovarian cancer growth through angiogenesis inhibition Hum Gene Ther 16 2005 957 970
131. A.P. Kusumbe, A.M. Mali, and S.A. Bapat CD-133-expressing stem cells associated with ovarian metastases establish an endithelial hierarchy and contribute to tumor vasculature Stem Cells 27 2009 498 508
132. A.B. Alvero, H.H. Fu, and J. Holmberg Stem-like ovarian cancer cells can serve as tumor vascular progenitors Stem Cells 27 2009 2405 2413
133. S. Deng, X. Yang, and H. Lassus Distinct expression levels and patterns of stem cell marker, aldehyde dehydrogenase isoform 1 (ALDH1), in human epithelial cancers PLoS One 5 2010 e10277
134. C.N. Landen Jr., B. Goodman, and A.A. Katre Targeting aldehyde dehydrogenase cancer stem cells in ovarian cancer Mol Cancer Ther 9 2010 3186 3199